Visual Abstract: Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at End of Life

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 5, 2021

Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.14785?guestAccessKey=8c17516a-be67-4503-badf-d947d3fec719&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100521

 

Visual Abstract


 

Authors: Harriëtte J. van Esch, M.D., of the Erasmus Medical Center Cancer Institute in Rotterdam, the Netherlands, is the corresponding author.

(doi:10.1001/jama.2021.14785)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.